Skip to Main Content

Paper Details

Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Genome Med
15
2018
ACMG, ACMG SF v2, LP, P, P/LP, P/LP variants, SF) genes, Secondary Findings (, VUS, cancer, cancer genes, familial cancer, gene
Author NameAffiliation
Jung KimClinical Genetics Branch, National Cancer Institute
Jung KimClinical Genetics Branch, National Cancer Institute
Wen LuoNational Cancer Institute, Inc.
Mingyi WangNational Cancer Institute, Inc.
Mingyi WangNational Cancer Institute, Inc.
Jennifer J JohnstonNational Human Genome Research Institute
Jennifer J JohnstonNational Human Genome Research Institute
Melissa RotunnoNational Cancer Institute
Michael DeanNational Cancer Institute
Neil E CaporasoNational Cancer Institute
Neil E CaporasoNational Cancer Institute
Lynn R GoldinNational Cancer Institute
Xiaohong R YangNational Cancer Institute
Xiaohong R YangNational Cancer Institute
Mia M Gaudet
Maria Teresa LandiNational Cancer Institute
Belynda HicksNational Cancer Institute, Inc.
Belynda HicksNational Cancer Institute, Inc.
Stephen J ChanockNational Cancer Institute
Stephen J ChanockNational Cancer Institute
Lisa MirabelloClinical Genetics Branch, National Cancer Institute
Lisa MirabelloClinical Genetics Branch, National Cancer Institute
Leslie G BieseckerNational Human Genome Research Institute
Leslie G BieseckerNational Human Genome Research Institute
Margaret A TuckerHuman Genetics Program National Cancer Institute
Margaret A TuckerHuman Genetics Program National Cancer Institute
Sharon A SavageClinical Genetics Branch, National Cancer Institute
Sharon A SavageClinical Genetics Branch, National Cancer Institute
Douglas R StewartClinical Genetics Branch, National Cancer Institute
Douglas R StewartClinical Genetics Branch, National Cancer Institute
  • 1 - 30

Datasets

Release 1.2